EssilorLuxottica Posts Double-Digit Growth in 2025, Driven by AI Glasses and Myopia Management
Event summary
- EssilorLuxottica reported FY 2025 revenue growth of 11.2% (€28.491B) and Q4 growth of 18.4%, with all regions growing double digits.
- AI-glasses sales exceeded 7 million units, contributing to revenue alongside strong performance in myopia management (+22% revenue).
- Adjusted operating margin was 16.0%, impacted by US tariffs and AI-glasses investments, but free cash flow hit a record €2.8B.
- The company proposed a €4.00 dividend with a scrip dividend option and updated its five-year outlook for solid revenue growth.
The big picture
EssilorLuxottica's strong FY 2025 results reflect its leadership in wearables and medtech, positioning it at the forefront of the AI-glasses revolution. The company's ability to navigate geopolitical risks and invest in innovation will be critical as it transitions into a broader medtech transformation. With record free cash flow and a revised five-year outlook, EssilorLuxottica is betting on sustained growth across its diversified portfolio.
What we're watching
- Innovation Pace
- How EssilorLuxottica will sustain momentum in AI-glasses and medtech amid macroeconomic uncertainty.
- Regulatory Impact
- Whether US tariffs will continue pressuring margins and how the company mitigates these headwinds.
- Execution Risk
- The pace at which EssilorLuxottica can scale its myopia management and audiology portfolios globally.
Related topics